Wexford Capital »

Arrivent Biopharma shares owned by Wexford Capital

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Wexford Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $29k 1.6k 18.45
2025-06-30 $120k 5.5k 21.77

More positions owned by Wexford Capital

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Mammoth Energy Svcs (TUSK)
Nephros (NEPH)
Core Natural Resources Com Shs (CNR)
EQT Corporation (EQT)
Chesapeake Energy Corp (EXE)
Energy Transfer Com Ut Ltd Ptn (ET)
Teekay Tankers Cl A (TNK)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Imperial Pete Com New (IMPP)
Acm Resh Com Cl A (ACMR)
Enterprise Products Partners (EPD)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Century Aluminum Company (CENX)
Antero Res (AR)

View all positions for Wexford Capital

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
Infinitum Asset Management
Suvretta Capital Management
FMR
OrbiMed Advisors
BlackRock
Vanguard Group
Octagon Capital Advisors
Novo A/S
Sofinnova Ventures
General Catalyst Group Management
State Street Corporation
Geode Capital Management
Siren
Sc China Holding

View all funds holding Arrivent Biopharma